Inhalation CDMO Market Report

Global and Region Inhalation CDMO Market Demand & Opportunity Outlook 2024

  • POSTDATE：Jan 16, 2024
  • PAGES：222
  • REPORT CODE：GMM1861438
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Many pharmaceutical companies possess limited in-house expertise to manufacture inhalation drugs, meaning they are increasingly opting to outsource inhalation drug development to contract development and manufacturing organizations (CDMOs) that have established production capabilities.

    The report details the trend, potential and market size of Inhalation CDMO market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Inhalation CDMOmarket, defines the market attractiveness level of Inhalation CDMO market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Inhalation CDMO industry, describes the types of Inhalation CDMO market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inhalation CDMO market and the development prospects and opportunities of Inhalation CDMO industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inhalation CDMO market in Chapter 13.

    By Player:

    • Sanner GmbH

    • Vectura Group Ltd

    • ICONOVO AB

    • Hovione

    • Gerresheimer AG

    • Honeywell International Inc

    • H&T Presspart

    • Stevanato Group

    • Recipharm AB

    • Medspray

    • Nemera

    • AptarGroup, Inc

    By Type:

    • Metered Dose Inhaler (MDIs)

    • Nebulizer

    • Dry Powder Inhaler (DPIs)

    • Soft Mist Inhaler

    By End-User:

    • Small and Medium-sized Pharmaceutical Companies

    • Big Pharmaceutical Companies

    • Others

    • Generic Pharmaceutical Companies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Inhalation CDMO Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Inhalation CDMO Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Inhalation CDMO Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Inhalation CDMO Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Inhalation CDMO Market Analysis and Outlook to 2022

    • 7.1 Global Inhalation CDMO Consumption (2017-2022)

    • 7.2 United States Inhalation CDMO Consumption (2017-2022)

    • 7.3 Europe Inhalation CDMO Consumption (2017-2022)

    • 7.4 China Inhalation CDMO Consumption (2017-2022)

    • 7.5 Japan Inhalation CDMO Consumption (2017-2022)

    • 7.6 India Inhalation CDMO Consumption (2017-2022)

    • 7.7 South Korea Inhalation CDMO Consumption (2017-2022)

    8 Region and Country-wise Inhalation CDMO Market Analysis and Outlook to 2028

    • 8.1 Global Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.2 United States Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.3 Europe Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.4 China Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.5 Japan Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.6 India Inhalation CDMO Consumption Forecast (2022-2028)

    • 8.7 South Korea Inhalation CDMO Consumption Forecast (2022-2028)

    9 Global Inhalation CDMO Market Outlook by Types and Applications to 2022

    • 9.1 Global Inhalation CDMO Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Metered Dose Inhaler (MDIs) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Nebulizer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dry Powder Inhaler (DPIs) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Soft Mist Inhaler Consumption and Growth Rate (2017-2022)

    • 9.2 Global Inhalation CDMO Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Small and Medium-sized Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Big Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Generic Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    10 Global Inhalation CDMO Market Outlook by Types and Applications to 2028

    • 10.1 Global Inhalation CDMO Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Metered Dose Inhaler (MDIs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Nebulizer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Dry Powder Inhaler (DPIs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Soft Mist Inhaler Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Inhalation CDMO Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Small and Medium-sized Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Big Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Generic Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Inhalation CDMO Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Inhalation CDMO Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Inhalation CDMO Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Inhalation CDMO Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Inhalation CDMO Market Competitive Analysis

    • 14.1 Sanner GmbH

      • 14.1.1 Sanner GmbH Company Details

      • 14.1.2 Sanner GmbH Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanner GmbH Inhalation CDMO Product and Service

    • 14.2 Vectura Group Ltd

      • 14.2.1 Vectura Group Ltd Company Details

      • 14.2.2 Vectura Group Ltd Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Vectura Group Ltd Inhalation CDMO Product and Service

    • 14.3 ICONOVO AB

      • 14.3.1 ICONOVO AB Company Details

      • 14.3.2 ICONOVO AB Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 ICONOVO AB Inhalation CDMO Product and Service

    • 14.4 Hovione

      • 14.4.1 Hovione Company Details

      • 14.4.2 Hovione Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hovione Inhalation CDMO Product and Service

    • 14.5 Gerresheimer AG

      • 14.5.1 Gerresheimer AG Company Details

      • 14.5.2 Gerresheimer AG Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Gerresheimer AG Inhalation CDMO Product and Service

    • 14.6 Honeywell International Inc

      • 14.6.1 Honeywell International Inc Company Details

      • 14.6.2 Honeywell International Inc Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Honeywell International Inc Inhalation CDMO Product and Service

    • 14.7 H&T Presspart

      • 14.7.1 H&T Presspart Company Details

      • 14.7.2 H&T Presspart Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 H&T Presspart Inhalation CDMO Product and Service

    • 14.8 Stevanato Group

      • 14.8.1 Stevanato Group Company Details

      • 14.8.2 Stevanato Group Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Stevanato Group Inhalation CDMO Product and Service

    • 14.9 Recipharm AB

      • 14.9.1 Recipharm AB Company Details

      • 14.9.2 Recipharm AB Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Recipharm AB Inhalation CDMO Product and Service

    • 14.10 Medspray

      • 14.10.1 Medspray Company Details

      • 14.10.2 Medspray Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Medspray Inhalation CDMO Product and Service

    • 14.11 Nemera

      • 14.11.1 Nemera Company Details

      • 14.11.2 Nemera Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Nemera Inhalation CDMO Product and Service

    • 14.12 AptarGroup, Inc

      • 14.12.1 AptarGroup, Inc Company Details

      • 14.12.2 AptarGroup, Inc Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AptarGroup, Inc Inhalation CDMO Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Inhalation CDMO

    • Figure Inhalation CDMO Picture

    • Table Global Inhalation CDMO Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inhalation CDMO Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inhalation CDMO Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Inhalation CDMO Consumption by Country (2017-2022)

    • Figure United States Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Table Europe Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Figure China Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Figure Japan Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Figure India Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Figure South Korea Inhalation CDMO Consumption and Growth Rate (2017-2022)

    • Figure Global Inhalation CDMO Consumption Forecast by Country (2022-2028)

    • Figure United States Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Inhalation CDMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metered Dose Inhaler (MDIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Nebulizer Consumption and Growth Rate (2017-2022)

    • Figure Global Dry Powder Inhaler (DPIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Soft Mist Inhaler Consumption and Growth Rate (2017-2022)

    • Figure Global Small and Medium-sized Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Big Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Metered Dose Inhaler (MDIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nebulizer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry Powder Inhaler (DPIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Soft Mist Inhaler Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small and Medium-sized Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Big Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Inhalation CDMO Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Inhalation CDMO Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanner GmbH (Foundation Year, Company Profile and etc.)

    • Table Sanner GmbH Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanner GmbH Inhalation CDMO Product and Service

    • Table Vectura Group Ltd (Foundation Year, Company Profile and etc.)

    • Table Vectura Group Ltd Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vectura Group Ltd Inhalation CDMO Product and Service

    • Table ICONOVO AB (Foundation Year, Company Profile and etc.)

    • Table ICONOVO AB Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICONOVO AB Inhalation CDMO Product and Service

    • Table Hovione (Foundation Year, Company Profile and etc.)

    • Table Hovione Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hovione Inhalation CDMO Product and Service

    • Table Gerresheimer AG (Foundation Year, Company Profile and etc.)

    • Table Gerresheimer AG Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gerresheimer AG Inhalation CDMO Product and Service

    • Table Honeywell International Inc (Foundation Year, Company Profile and etc.)

    • Table Honeywell International Inc Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Honeywell International Inc Inhalation CDMO Product and Service

    • Table H&T Presspart (Foundation Year, Company Profile and etc.)

    • Table H&T Presspart Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table H&T Presspart Inhalation CDMO Product and Service

    • Table Stevanato Group (Foundation Year, Company Profile and etc.)

    • Table Stevanato Group Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stevanato Group Inhalation CDMO Product and Service

    • Table Recipharm AB (Foundation Year, Company Profile and etc.)

    • Table Recipharm AB Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recipharm AB Inhalation CDMO Product and Service

    • Table Medspray (Foundation Year, Company Profile and etc.)

    • Table Medspray Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medspray Inhalation CDMO Product and Service

    • Table Nemera (Foundation Year, Company Profile and etc.)

    • Table Nemera Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nemera Inhalation CDMO Product and Service

    • Table AptarGroup, Inc (Foundation Year, Company Profile and etc.)

    • Table AptarGroup, Inc Inhalation CDMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table AptarGroup, Inc Inhalation CDMO Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US